AKT1 and melanoma: Mutations of key proteins in the RAS/RAF/MEK/ERK and PI3K/Akt/mTOR signaling cascades were described in malignant melanoma including BRAF (35–60%), NRAS (15–30%), and PTEN (8–15%) [3,4,5].